Dysentery clinical trials
The registry lists 64 studies for Dysentery across more than 10 countries. 9 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-14.
Status
- Completed
- 40
- Recruiting
- 7
- Status unknown
- 6
- Terminated
- 4
- Withdrawn
- 3
- Not yet recruiting
- 2
Phase
- Phase 2
- 15
- Phase 3
- 10
- Phase 1
- 9
- Phase 4
- 5
Where
- United States
- 12
- Bangladesh
- 7
- Mexico
- 6
- India
- 4
- France
- 4
- Germany
- 4
Who runs them
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd (4) · Johns Hopkins Bloomberg School of Public Health (4) · Intercell USA, Inc. (3) · Assistance Publique - Hôpitaux de Paris (2) · Cosmo Technologies Ltd (2) · RedHill Biopharma Limited (2) · GlaxoSmithKline (2) · The University of Texas Health Science Center, Houston (2)
Studies
Recruiting first, then most recently updated. Showing 50 of 64 — search for more.
- VE303 for Prevention of Recurrent Clostridioides Difficile InfectionRecruitingNCT06237452Phase 324 countries
- Testing a Scalable Model of the Cholera Hospital-Based Intervention for 7 Days (CHoBI7)RecruitingNCT06498817Not applicable1 country
- The Impact of Shigellosis and Recommended Treatment in ChildrenRecruitingNCT07433426Phase 22 countries
- Preventative Intervention for Cholera for 7 DaysRecruitingNCT05166850Not applicable1 country
- Early Life Malnutrition, Environmental Enteric Dysfunction and Microbiome TrajectoriesRecruitingNCT071950061 country
- InvaplexAR-Detox and DmLT Adjuvant in the Netherlands and ZambiaRecruitingNCT05961059Phase 11 country
- Probiotics Administration Via Colonoscopic Spray and Oral Administration in CDAD PatientsRecruitingNCT05770726Not applicable1 country
- Study to Evaluate Safety and Efficacy of Rifamycin SV MMX in Treating Traveler's Diarrhea in Children Age 12 to 17 YearsNot yet recruitingNCT04027894Phase 2
- Evaluate Safety and Efficacy of Rifamycin SV MMX in the Treatment of Traveler's Diarrhea in Children Age 6 to 11 YearsNot yet recruitingNCT04026984Phase 2
- The Utility and Feasibility of Accessible Diarrhea Etiology Prediction Tool (ADEPT) in an Informal Healthcare SettingActive, not recruitingNCT07538531Not applicable1 country
- Clinical Study to Assess the Efficacy of Once-daily IMM-124E (Travelan®) in a Controlled Human Infection Model.CompletedNCT05933525Phase 21 country
- Clinical Trial of the S. Flexneri-S. Sonnei Bivalent Conjugate VaccineActive, not recruitingNCT06838195Phase 31 country
- Pilot Trial of a Clinical Decision-Support App for Managing Emergencies Among Clinicians in a Rural Ugandan HospitalCompletedNCT07257705Not applicable1 country
- Lactobacillus Acidophilus and Limosilactobacillus Reuteri for Acute Diarrhea in ChildrenCompletedNCT07342088Not applicable1 country
- Study in Healthy Adults Challenged With Enterotoxigenic E. Coli, of the Safety, Tolerability and Anti-Diarrheal Activity of VENBETA6890, an Orally Administered, Human Monoclonal IgACompletedNCT06896136Phase 11 country
- Ciprofloxacin Versus Azithromycin for Children Hospitalised With DysenteryCompletedNCT03854929Phase 41 country
- Clinical Decision Rules in the Emergency Department to Improve the Management of Acute Respiratory Infection and Acute Infectious DiarrheaCompletedNCT053226941 country
- Etiological Diagnosis of Traveler's DiarrhoeaCompletedNCT02866201Not applicable1 country
- GastroIntestinal Panel in Kidney Transplant PatientsStatus unknownNCT05722119Phase 3
- Trial Evaluating Chemoprophylaxis Against Travelers' Diarrhea - Prevent TDCompletedNCT02498301Not applicable2 countries
- Auranofin for Giardia ProtozoaCompletedNCT02736968Phase 21 country
- Film Array Gastrointestinal Panel Compared to Usual Care for ED Evaluation of Infectious DiarrheaTerminatedNCT03809117Not applicable1 country
- Immunological Characteristics of a Population at Risk of Cholera After Oral Cholera Vaccine (CHOVAXIM)CompletedNCT04423159Not applicable1 country
- A Baseline Study in Support of Clinical Evaluation of an Oral Shigella Vaccine Development in AfricaCompletedNCT043129062 countries
- Concomitant Infection of Intestinal Parasites and Helicobacter PyloriStatus unknownNCT053609401 country
- Phase 1 Trial for Safety, Tolerability, and Immunogenicity of a Live, Attenuated, Oral Shigella/ETEC Combination Vaccine to Healthy AdultsCompletedNCT05409196Phase 11 country
- Results of FilmArray® Gastro-intestinal Panel and Serum Procalcitonin in Acute Colitis and Infectious Diarrhea in the ERCompletedNCT04237181Not applicable1 country
- Immunogenicity and Safety of S.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine in Volunteers Aged From 3 Months to 5 Years OldCompletedNCT04865497Phase 21 country
- Efficacy, Immunogenicity and Safety of S. Flexneriza-S. Sonnei Bivalent Conjugate Vaccine in Volunteers Aged From 6 Months to 5 YearsStatus unknownNCT05156528Phase 31 country
- Immunochromatography Versus Microscopy for Diagnosis of Entamoeba Histolytica/Dispar Infection.Status unknownNCT047599371 country
- Creation of an E-toileting Log Through Classification of the Physical Properties of Stool and Urine Using TrueLoo™CompletedNCT050086401 country
- The Acceptability and Impact of Diarrheal Etiology Prediction (DEP) AlgorithmCompletedNCT04602676Not applicable2 countries
- Safety and Immunogenicity of Artificial Invaplex (Shigella Flexneri 2a InvaplexAR)CompletedNCT02445963Phase 11 country
- A Study to Evaluate the Efficacy, Safety and Immunogenicity of a Vaccine Designed to Protect Against Infection With Shigella Sonnei in Healthy AdultsCompletedNCT03527173Phase 21 country
- Efficacy and Safety of CB-01-11 200mg Tablets in Infectious DiarrhoeaCompletedNCT03447821Phase 2
- Traveler's Diarrhea (TD) Automated ProcessCompletedNCT00751777Phase 21 country
- ESBL in Patients Returning to Sweden With Traveller's DiarrhoeaCompletedNCT038662911 country
- A Study to Evaluate Safety and Immunogenicity of 1 Booster Dose of 1790GAHB Vaccine in Healthy Adults Primed With 3 Doses of 1790GAHB Vaccine in Study H03_01TP Compared to 1 Vaccination of 1790GAHB in Either Subjects Who Received Placebo in the Same Study or naïve Subjects Not Part of H03_01TP StudyCompletedNCT03089879Phase 11 country
- A Study Comparing Two Rifaximin Tablets in Patients With Travelers' Diarrhea.TerminatedNCT02920242Phase 31 country
- Rifamycin SV-MMX® Tablets Versus Ciprofloxacin Capsules in Acute Traveller's DiarrhoeaCompletedNCT01208922Phase 33 countries
- Anaemetro I.V. Infusion 500mg Drug Use InvestigationCompletedNCT03491228
- Efficacy of Rifaximin in Preventing CampylobacteriosisCompletedNCT02280044Phase 2/31 country
- Safety and Efficacy Study of WRSS1, a Shigella Sonnei Vaccine CandidateCompletedNCT01080716Phase 1/21 country
- Safety Study of S.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine in Healthy Volunteers Aged Above 3 MonthsCompletedNCT03561181Phase 11 country
- Study to Evaluate Safety and Efficacy of Rifamycin SV Multi-Matrix System (MMX) for the Treatment of Traveler's Diarrhea (TD)CompletedNCT01142089Phase 32 countries
- SF2a-TT15 Conjugate Vaccine in Healthy Adult VolunteersCompletedNCT02797236Phase 11 country
- Safety, Immunogenicity and Efficacy Study of Inactivated Whole Cell Shigella Flexneri 2a Vaccine With and Without dmLT in AdultsWithdrawnNCT03038243Phase 21 country
- Clinical Trial of CBS-2004 in Prevention of Travelers' DiarrheaWithdrawnNCT02736539Phase 3
- Improving the Quality of Private Sector Health Care in West BengalCompletedNCT02291575Not applicable
- Trial Evaluating Ambulatory Treatment of Travelers' DiarrheaTerminatedNCT01618591Not applicable5 countries